Trial record 5 of 91 for: "Brain Diseases" AND "Multiple System Atrophy"
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00750867|
Recruitment Status : Completed
First Posted : September 11, 2008
Results First Posted : October 26, 2015
Last Update Posted : February 23, 2017
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Peter Novak, University of Massachusetts, Worcester
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Multiple System Atrophy
Drug: intravenous immunoglobulin (IVIg)
The main study limitation is its small size and open label character.